APPROVAL OF EXPANDED PRK INDICATIONS BASED ON 100-200 PATIENTS, SUGGESTED BYPANEL; "OFFSHOOT" INDICATIONS INCLUDE HIGH MYOPIA, ASTIGMATISM
This article was originally published in The Gray Sheet
Clearance of additional indications for excimer lasers approved for photorefractive keratectomy could be based on studies with as few as 100-200 patients followed up for six months, FDA's Ophthalmic Devices Panel concluded at a July 26 meeting in Gaithersburg, Maryland.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.